Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Valeant Pharmaceuticals Intl (NY: VRX)
N/A USD  UNCHANGED
Last Price  /  Updated:   /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 0
Open -
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close -
Today's Range N/A - N/A
52wk Range 10.94 - 27.79
Shares Outstanding 348,708,567
Dividend Yield N/A
Performance
Top News
More News
Bausch Health Announces Publication Of Pivotal Phase 3 Efficacy And Safety Data On ALTRENO™ (tretinoin) Lotion, 0.05% In The Journal Of Drugs In Dermatology
Bausch Health Companies Inc. (NYSE/TSX: BHC) and its dermatology business, Ortho Dermatologics, one of the largest prescription dermatology health care businesses, today announced that the Journal of... Read More
from PR Newswire
International Ophthalmology and Optometry Devices Market Booming With New Growth Opportunities
from PR Newswire
More News
Read More
Bausch + Lomb Announces U.S. FDA Filing Acceptance For Loteprednol Etabonate Ophthalmic Gel, 0.38%
from PR Newswire
Salix And US WorldMeds Enter Into Exclusive Co-Promotion Agreement For Opioid Withdrawal Treatment LUCEMYRA™ (lofexidine)
from PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valeant Pharmaceuticals International, Inc. - VRX
from ACCESSWIRE
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valeant Pharmaceuticals International, Inc. - VRX
from PR Newswire
TD Ameritrade Traders Adopt Some Old And New Approaches To The Trade War Market In June's IMX
category TD Ameritrade , IQ , General , and 19 more.
from Benzinga
Interesting VRX Put And Call Options For August 10th
category Stocks
from Market News Video
2,800 Tuesday and the S&P – Are We There Yet?
category ETFs , Futures , Stocks / Equities
from Blogs - TalkMarkets
Valeant is back on to its old drug-pricing ways
category Commodities , Pharmaceuticals , VRX , and 4 more.
from MarketWatch
Reviewing Bill Ackman's Q1 Trading Activity: Sells Nike and Howard Hughes
category TGT , General , Hedge Funds , and 12 more.
from Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.